YOLO-geochemical integration for real-time aeolian dust monitoring: a critical review of signatures, health risks, and policy implications
Abstract
Aeolian dust is one of the most pervasive natural air pollutants, strongly influencing atmospheric chemistry, visibility, climate feedback, and human health. This review critically evaluates the integration of geochemical fingerprinting techniques and YOLO-based deep learning frameworks for real-time aeolian dust monitoring, with the overarching objective of advancing source attribution, health risk assessment, and evidence-based policy formulation in dust-prone regions. The Middle East, particularly the Qatar Peninsula, experiences recurrent dust storms that transport mineral particles and trace metals, contributing to degraded air quality, reduced solar energy efficiency, and elevated risks of respiratory and cardiovascular diseases. Traditional monitoring approaches including satellite observations, ground-based measurements, and geochemical analyses such as inductively coupled plasma mass spectrometry (ICP-MS), scanning electron microscopy with energy dispersive spectroscopy (SEM-EDS), and X-ray diffraction (XRD) have improved source apportionment and compositional understanding, yet they often lack real-time detection and high-resolution spatiotemporal coverage. Emerging artificial intelligence (AI) tools, particularly the You Only Look Once (YOLO) deep learning framework, offer transformative opportunities for atmospheric dust monitoring by enabling rapid, automated plume detection across multispectral and hyperspectral datasets. This review demonstrates that ICP-MS,…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.